ABSTRACT BACKGROUND: Blunt thoracic injury often leads to pulmonary contusion and the development of acute respiratory distress syndrome, which carries a high risk of morbidity and mortality, originating from the local and systemic inflammatory states. This study aimed to investigate the local and systemic antiinflammatory effects of levosimendan in rat models of blunt chest trauma.
INTRODUCTION
The pulmonary contusion (PC) table associated with blunt chest trauma is a clinical table observed with alveolar conges-drome (ARDS). [5] [6] [7] Blunt chest trauma and PC, which develops with all of these features, have a high risk of morbidity and mortality. [8, 9] Levosimendan increases the affinity of Ca2+ to troponin C (TnC) and is a pyridazinone-dinitrile-derived class III Ca2+-sensitizing agent. By providing a dose-dependent connection of Ca2+ to the TnC N-terminal region, troponin activation is provided by inhibiting troponin I (TnI) and TnC-Ca2+ stabilization. [10] At the same time, levosimendan is a new drug that increases cardiac output with positive inotropic and vasodilation properties, without increasing the need for myocardial oxygen consumption. It has also been shown in the literature that besides these properties, oxidative pulmonary damage associated with reperfusion and inflammatory cytokines (IL-1, IL-6, TNF-α, etc.) in ventilator-related pulmonary damage and sepsis experimental models are reduced, and cellular level inflammation and proinflammatory responses are suppressed. [11] [12] [13] [14] This study outlines the therapeutic properties and effects of levosimendan on the potential systemic antiinflammatory response in an experimental rat model of unilateral PC.
MATERIALS AND METHODS

Material
This experimental study was performed according to the guidelines for the use of laboratory animal subjects in research set by the Ethics Committee of Kırıkkale University (Date: 02.13.2014; Number: 14/03-33).
In this experimental study, the experimental agent levosimendan (Simdax, Orion Corporation, Finland) was intravenously infused at a low dose (5 µg/kg loading dose for 10 min, followed by 0.05 µg/kg/min maintenance dose) and a high dose (10 µg/kg loading dose for 10 min and 0.1 µg/kg/min maintenance dose). The oral LD50 dose of levosimendan is defined as 980 mg/kg in rats.
A total of 32 male Wistar albino rats, each weighing 300-350 g, were used in the study. The number of rats to be included in the groups was determined based on similar studies in the literature, and the number of rats to be used was confirmed by power analysis. The rats were randomly allocated to one of the following four groups.
-Control group (n=8; sedation anesthesia was administered but no contusion was induced) -Sham group (n=8; after inducing contusion, 1.5 ml/100 g/h of physiological saline was intravenously administered) -Low-dose levosimendan (LDL) group (after inducing contusion, levosimendan was administered as a 5-µg/kg loading dose for 10 mins, followed by 0.05 µg/kg/min as an intravenous infusion)
-High-dose levosimendan (HDL) group (after inducing contusion, levosimendan was administered as a 10-µg/kg loading dose for 10 mins, followed by 0.1 µg/kg/min as an intravenous infusion)
For sedation anesthesia, 40 mg/kg ketamine HCl (Ketalar® 5%; Pfizer Inc., USA) and 5 mg/kg xylazine HCl (Rompun® 2%; Bayer HealthCare AG, Germany) were intraperitoneally administered.
Method
With all rats under sedation anesthesia, a vascular route was opened from the tail veins using a 24G yellow intracatheter.
Invasive monitorization was performed for 6 h for each rat fixed on a fixation plate, the left femoral artery was explored, and a catheter was placed in the artery under microscope guidance. After these preparatory procedures, unilateral pulmonary injury was induced in the right hemithorax of each rat via a modified form of the trauma mechanism developed by Raghavendran et al. (with the method of a 0.5 kg cylindrical body falling from a height of 0.4 m; energy created, E=1.96 J) (Fig. 1) . [15] To reduce cardiac injury to a minimum and have a minimum effect on hemodynamic instability, the contusion was unilaterally induced to the right lung.
Then, keeping the control group aside, the rats of the sham group were administered 1.5 ml/100 g/h of physiological saline infusion; those of the LDL group were administered levosimendan as a 5-µg/kg loading dose for 10 min, followed by 0.05 µg/kg/min intravenous infusion; and those of the HDL group were administered levosimendan as a 10-µg/kg loading dose for 10 min, followed by 0.1 µg/kg/min intravenous infusion. Throughout the experiment, systolic and diastolic blood pressures, mean arterial pressures, and heart rates (HRs) of all rats were monitored and recorded (Fig. 1) . The rats were kept warm under a blanket throughout the experiment, and oxygen support was provided. After 6 h, median sternotomy was performed for all the rats under anesthesia, and euthanasia was performed by draining all the blood from the body via the cardiac route. The right lung was completely excised from each rat. The tissues and blood samples obtained were used for pathological, Immunohistochemical, and biochemical analysis.
Histopathological Evaluation
After fixation of the pulmonary tissues obtained in 10% formaldehyde solution, the samples were embedded in paraffin blocks, and then, 5-µm-thick slices were cut and stained with hematoxylin and eosin. The preparates obtained were evaluated using a light microscope (Leica DM 2500) by an experienced pathologist who was blinded to the study groups. The areas of lung contusion were classified according to the presence of neutrophil infiltration, alveolar hemorrhage, alveolar congestion, and hyaline membrane formation, as described below (Fig. 2 ).
-Grade 0: minimal damage -Grade 1: little damage -Grade 2: moderate damage -Grade 3: severe damage
Immunohistochemical Evaluation
Pulmonary tissues were washed with 4% paraformaldehyde, and after dehydration, they were embedded in paraffin blocks. Using standard histological techniques, 5-µm-thick slices were cut. All slices were heated at 60°C for 60 min in an oven and then deparaffinized. After the endogenous peroxidase reaction, blocking was performed using 3% H2O2 for 30 min. The samples were then washed thrice using a phosphate-buffered solution and incubated overnight in a solution of anti-rat NF-κB polyclonal antibody (Santa Cruz, CA, USA), which was diluted at room temperature 1/100 with primary rabbit. Biotin peroxide and diaminobenzidine brown-yellow colors were used in the development of the findings. The results obtained were evaluated by an experienced pathologist who was blinded to the study groups, and the NF-κB values in each slice were classified under a microscope (BenchMark GX, Ventana Medical Systems Inc.) using the histopathological classification method stated above.
Biochemical Evaluation
The blood samples obtained from the rats were centrifuged at 3000 rpm for 10 mins; the serum samples were collected and immediately frozen in dry air at −80°C and stored until analysis. All serum samples were evaluated with respect to IL-1β, IL-6, TNF-α, and NO levels by an experienced biochemist who was blinded to the study groups. The Platinum ELISA kit method was used for all serum samples (Affymetrix, eBioscience Inc., USA), and the results were calculated as pg/ml for IL-1β and IL-6, ng/L for TNF-α, and as μmol/L for NO.
Statistical Analysis
All statistical analyses were conducted using the SPSS 22.0 statistical software (SPSS Inc., Chicago IL, USA).
The histopathological grades and TNF-α levels that were not normally distributed and the variation was not homogenous between all groups were statistically analyzed using Kruskal-Wallis test. To determine the statistical differences between the groups (post hoc evaluation), Mann-Whitney U test (with Bonferroni correction) was performed for all grade results. p values of <0.0083 were considered to be significant.
The values of the hemodynamic parameters and IL-1β, IL-6, and NO levels were normally distributed, and the variations were homogenous among the groups. Therefore, oneway analysis of variance (ANOVA) was performed for all the values. To determine the statistical differences between the groups, post hoc evaluation (one-way ANOVA-Tukey multiple comparisons test) was performed. p values of <0.05 were considered to be significant.
RESULTS
Hemodynamic Measurement Evaluation
Throughout the 6 h of the experiment, the systolic and dia- stolic blood pressures, mean arterial pressures, and HRs of all the rats were monitored and recorded. After inducing the trauma, bradycardia and hypotension developed in all the rats. At 20 min after the trauma, HR values were significantly higher in the LDL and HDL groups than in the sham group (p=0.031). The mean arterial pressure values tended to be high in the sham group after 30 min, and after 6 h, the values reached the baseline values. In the LDL and HDL groups, the mean arterial pressure values were observed to be low throughout the experiment, with no statistically significant difference observed between the groups.
Histopathological Evaluation
Statistical analysis of the results of the histopathological exAteş et al. Evaluation of the systemic antiinflammatory effects of levosimendan in an experimental blunt thoracic trauma model Fig. 3 ).
A statistically significant difference was determined among the following groups with respect to alveolar congestion: control/sham (Z=−3.340; p=0.001); control/LDL (Z=−3.354; p=0.001), and control/YDL (Z=−2.887; p=0.004). No difference was observed among the groups with regard to the reduction of alveolar congestion. In addition, a statistically significant difference was determined among the groups with regard to alveolar hemorrhage: control/sham (Z=−3.332; p=0.001) and control/LDL (Z=−2.912; p=0.004). No difference was observed among the groups with respect to the reduction of alveolar hemorrhage.
A statistically significant difference was determined among the groups with respect to neutrophil infiltration: control/ sham (Z=−3.359; p=0.001), sham/YDL (Z=−2.646; p=0.008), and sham/LDL (Z=−2.988; p=0.003). Neutrophil infiltration was higher in the sham group than in the other groups. From this, it was determined that LDL and HDL reduced neutrophil infiltration in the pulmonary tissue with contusion (Table 3) .
Immunohistochemical Evaluation
NF-κB levels were different among all the groups: control/sham (Z=−3.385; p=0.001), control/LDL (Z=−1.118; p=0.001), and 1  1  1  1  1  2   2  2  2  2  3  3  3  3   2  2  2  2  3  3  3  3  2 control/YDL (Z=−3.335; p=0.001) ( Table 3) . Although NF-κB levels were not statistically significantly different among the groups, the levels were numerically lower in the LDL and HDL groups than in the control and sham groups.
Biochemical Evaluation
Statistical analysis of the results of the biochemical evaluation revealed a difference among the groups with respect to the serum levels of IL-1β (F=16.719; p<0.001), IL-6 (F=4.955; p=0.007), NO (F=4.855; p=0.008), and TNF-α (X 2 =11.994; p=0.007) ( Table 4, 5, Fig. 4) .
A statistically significant difference was determined among the groups regarding serum IL-1β levels: control/sham (p<0.001), control/LDL (p=0.022), sham/LDL (p=0.005), sham/LDL (p<0.001), and LDL/YDL (p=0.005). Reduced serum IL-1β levels were observed in the LDL and HDL groups.
A statistically significant difference was determined among the groups with regard to serum IL-6 levels: sham/LDL (p=0.028) and sham/YDL (p=0.008). The use of HDL significantly reduced serum IL-6 levels.
A statistically significant difference was determined with respect to serum NO levels only between the sham/YDL (p=0.005) and LDL/YDL (p=0.006) groups (Table 5) . HDL significantly reduced serum NO levels.
Serum TNF-α levels were different only between the control/ sham (Z=−2.941; p=0.003) groups (Table 3) .
DISCUSSION
Previous studies demonstrated that the effect of chest trauma increased with the occurrence of respiratory complications, such as ALI/ARDS, associated with the trauma severity. [16] [17] [18] In patients with multiple trauma, if PC occurs, the mortality rate increases from 27% to 56%. In addition, animal experimental studies revealed that after trauma, there are severe local and systemic inflammatory changes, which potentially trigger septic complications, and the organ failure that first develops in this table is respiratory failure. [19] In the current study, an increase in the systemic inflammatory response and development of severe bradycardia and hypotension, as a clinical reflection, were observed more in the trauma groups than in the control group. In the LDL and HDL groups, where doses administered were similar to those in used in the clinical practice, the mean arterial pressure significantly reduced. In the clinical practice, levosimendan is administered for hypotension, and so, to observe the effect on hypotension in the current study, the following two different doses were administered: 5 µg/kg loading dose for 10 min, followed by 0.05 µg/kg/min intravenous infusion, and 10 µg/kg loading dose for 10 min, followed by 0.1 µg/kg/min intravenous infusion. No statistically significant differences were observed with regard to the mean arterial blood pressure or heart rate in the LDL and HDL groups. PC, which is widely observed after blunt thorax trauma, is an injury that may result in morbidity and mortality. [20] In the current study, because the results of the histopathological examination of pulmonary tissues obtained 6 h after the formation of blunt thorax trauma, which included alveolar hemorrhage, alveolar edema, and neutrophil infiltration, were similar to the those of the trauma model described by Raghavendran et al., the efficacy of the current study model was confirmed. [15] According to these results, PC model was successfully established in the rats. After analyzing the results obtained from the histopathological examination in this study, although a statistical difference was not observed, when the median values were examined, the high dose of levosimendan was considered to reduce alveolar hemorrhage that developed after trauma; however, when a low dose was administered, no effect on alveolar hemorrhage was observed. In addition, at both low and high doses, levosimendan reduced neutrophil infiltration in damaged pulmonary tissues. However, levosimendan did not have any effect on reducing alveolar congestion. Based on these findings, it was considered that levosimendan did not reduce alveolar congestion but was effective in reducing inflammatory cell infiltration and alveolar hemorrhage in PCs that developed after blunt thoracic trauma.
In experimental studies of pulmonary damage, an intense inflammatory response developed in damaged tissues, and the chemokines that were particularly expressed by alveolar macrophages activated neutrophils. [21] It has been proposed that reactive oxygen radicals, tissue fragmenting proteinases, and cationic polypeptides in proinflammatory cytokines (e.g., IL-1β, IL-6, TNF-α, and NO), expressed by active neutrophils, are a risk factor for increase in tissue damage and the development of ARDS. [22] NF-κB, a proinflammatory factor, has a regulatory role in the emergence of several of the abovementioned mediators. [7] In an experimental animal model study by Perl et al., [23] the inflammatory effects of PC were examined in mononuclear cells in the peripheral blood, peritoneal macrophages, splenocytes, and splenic macrophages and on plasma TNF-α and IL-6 levels. At the end of the study, it was reported that PC caused severe immune function impairment systemically and in different compartments.
In the current study, PC induced in the rats increased NF-κB activation in the pulmonary tissue, and levosimendan did not reduce this activation. Although statistical analysis did not reveal any difference between the groups, the TNF-α formation could have been suppressed in the serum samples of the LDL and HDL groups. While the serum IL-1β level reduced after administration of low and high doses of levosimendan, serum IL-6 and NO levels reduced with high doses only. In the current study, serum levels of the proinflammatory cytokines IL-1β and TNF-α significantly increased in the sham group compared with those in the control group. These results suggested that proinflammatory cytokine formation after blunt thoracic trauma was suppressed by levosimendan.
Limitations
This study had some limitations. First, this study evaluated the effects of levosimendan on the systemic inflammatory response, but for technical and financial reasons, advanced biochemical and histopathological examination of inflammatory response inhibitors, which are developed in damaged pulmonary tissues, were not performed. Second, the low and high doses of levosimendan used in this study were within the dose ranges recommended in the guidelines for the diagnosis and treatment of acute heart failure; therefore, it would be appropriate to conduct further studies of higher doses and assess the long-term effects of such doses. If a more significant increase is observed in the antiinflammatory properties of HDL compared LDL, the selection of the dose to be used should be patient-based in the clinical use. Therefore, considering the effects of the local and systemic response on mortality following PC development after thorax trauma, further studies over a longer term with higher doses would be useful with respect to clinical safety. Third, owing to technical and financial restrictions, arterial blood gas analysis was not performed, and saturation was not monitored.
Conclusion
In conclusion, the study results revealed that in a rat model of PC, the experimental agent levosimendan could reduce neutrophil infiltration to damaged pulmonary tissues and decrease the systemic release of some cytokines (such as IL-1β, IL-6, and NO), thus partially reducing and/or correcting pulmonary damage. Therefore, levosimendan is considered to reduce systemic inflammatory responses that occur after trauma and is clinically beneficial for patients with PC. 
